熱門資訊> 正文
Processa Pharmaceuticals申请5000万美元混合货架
2024-05-22 04:29
- Processa Pharmaceuticals (NASDAQ:PCSA) on Tuesday filed a prospectus for a mixed securities shelf offering of up to $50M.
- This prospectus is not an offer to sell these securities.
- SEC Filing
More on Processa Pharmaceuticals
- POET, PCSA and BRFH are among premarket gainers
- Seeking Alpha’s Quant Rating on Processa Pharmaceuticals
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。